PharmaBio HIT-Digest < 기사목록

편집. 2025-11-26 12:40 (수)

한국어

ENG

中文

にほんご

Baraclude Experiences Consecutive Price Reductions Following New Drug Approvals
제약 Sodam Park reporter 2023.07.31 04:39
Coverage Uncertainty for Novo Nordisk’s Ozempic Diabetes Drug as Mounjaro’s Reimbursement Status Remains in Question
제약 Sodam Park reporter 2023.07.31 04:38
SN BioScience Receives FDA Orphan Drug Designation for Nano-Anticancer Drug Targeting Small Cell Lung Cancer
바이오 Sodam Park reporter 2023.07.24 08:50
Lixiana’s NCE Patent Worth $70 Million Broken after First Challenge in 5 Years
제약 Sodam Park reporter 2023.07.21 12:25
Medytox Enters Vietnamese Market with Neuraderm Supply Contract through PCVN Partnership
바이오 Sodam Park reporter 2023.07.20 15:14
Pre-Approval Rates of Zolgensma and Crysvita Surpass 80%
건강보험 Sodam Park reporter 2023.07.20 15:01
GC Biopharma Submits FDA Approval Application for Blood Product, ‘ALYGLO’
제약 Sodam Park reporter 2023.07.18 18:13
Celltrion's Merger Plan for Three Listed Companies: Will it Be Fully Executed?
바이오 Sodam Park reporter 2023.07.18 18:10
Daewoong Bio Invests $50 Million in Antibiotics to Expand Business to $100 Million
제약 Sodam Park reporter 2023.07.18 18:00
Takeda Announces Call for Proposals in search of 'Pilots to New Drug Discovery'
기획 Sodam Park reporter 2023.07.17 05:30
Huons Biopharma Obtains EU GMP Certification for Second Hutox Production Plant
바이오 Sodam Park reporter 2023.07.14 15:45
South Korea Medical Device Sector Shines in the First Half of 2023
의료기기 Sodam Park reporter 2023.07.14 04:41
Leclaza Receives Expanded Indications as First-Line Treatment for EGFR-Positive Lung Cancer
제약 Sodam Park reporter 2023.07.12 05:21
Samsung Biologics Expedites Alzheimer's Disease CMO Project in Anticipation of Lecanemab FDA Approval
바이오 Sodam Park reporter 2023.07.04 05:08
HK Inno.N's K-CAB Receives Reimbursement for Five Indications
제약 Sodam Park reporter 2023.06.29 06:11
Celltrion Receives FDA Approval for Phase 3 Clinical Trial of CT-P53
바이오 Sodam Park reporter 2023.06.27 18:40
Daewoong Pharmaceuticals Strengthens Global Market Presence at IMCAS ASIA 2023
제약 Sodam Park reporter 2023.06.26 05:59
Hanmi Confirms New Indication for Returned New Drug
제약 Sodam Park reporter 2023.06.15 17:00
AZ Korea Sent Legal Warning to Generic Manufacturers of Farxiga
제약 Sodam Park reporter 2023.06.15 14:00
Samsung Biologics has Strategically Partnered with Pfizer for the Long-Term Production of Pfizer's Biosimilars
바이오 Sodam Park reporter 2023.06.12 17:15

상단영역

본문영역

PharmaBio HIT-Digest 목록 ( 총 : 580건)

기사목록 보기 형태

Baraclude Experiences Consecutive Price Reductions Following New Drug Approvals

Coverage Uncertainty for Novo Nordisk’s Ozempic Diabetes Drug as Mounjaro’s Reimbursement Status Remains in Question

SN BioScience Receives FDA Orphan Drug Designation for Nano-Anticancer Drug Targeting Small Cell Lung Cancer

Lixiana’s NCE Patent Worth $70 Million Broken after First Challenge in 5 Years

Medytox Enters Vietnamese Market with Neuraderm Supply Contract through PCVN Partnership

Pre-Approval Rates of Zolgensma and Crysvita Surpass 80%

GC Biopharma Submits FDA Approval Application for Blood Product, ‘ALYGLO’

Celltrion's Merger Plan for Three Listed Companies: Will it Be Fully Executed?

Daewoong Bio Invests $50 Million in Antibiotics to Expand Business to $100 Million

Takeda Announces Call for Proposals in search of 'Pilots to New Drug Discovery'

Huons Biopharma Obtains EU GMP Certification for Second Hutox Production Plant

South Korea Medical Device Sector Shines in the First Half of 2023

Leclaza Receives Expanded Indications as First-Line Treatment for EGFR-Positive Lung Cancer

Samsung Biologics Expedites Alzheimer's Disease CMO Project in Anticipation of Lecanemab FDA Approval

HK Inno.N's K-CAB Receives Reimbursement for Five Indications

Celltrion Receives FDA Approval for Phase 3 Clinical Trial of CT-P53

Daewoong Pharmaceuticals Strengthens Global Market Presence at IMCAS ASIA 2023

Hanmi Confirms New Indication for Returned New Drug

AZ Korea Sent Legal Warning to Generic Manufacturers of Farxiga

Samsung Biologics has Strategically Partnered with Pfizer for the Long-Term Production of Pfizer's Biosimilars